.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Novartis
Harvard Business School
Chubb
Cipla
Baxter
AstraZeneca
Colorcon
Deloitte
US Army

Generated: July 25, 2017

DrugPatentWatch Database Preview

RIBAVIRIN Drug Profile

« Back to Dashboard

Which patents cover Ribavirin, and when can generic versions of Ribavirin launch?

Ribavirin is a drug marketed by Aurobindo Pharma, Zydus Pharms Usa, Sandoz, Sandoz Inc, Teva, Kadmon Pharms Llc, and Navinta Llc. and is included in ten NDAs.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the ribavirin profile page.

Summary for Tradename: RIBAVIRIN

Patents:0
Applicants:7
NDAs:10
Suppliers / Packagers: see list11
Bulk Api Vendors: see list63
Clinical Trials: see list918
Patent Applications: see list8,545
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIBAVIRIN at DailyMed

Pharmacology for Tradename: RIBAVIRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
RIBAVIRIN
ribavirin
TABLET;ORAL079111-001Sep 17, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa
RIBAVIRIN
ribavirin
TABLET;ORAL077094-003Mar 16, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
RIBAVIRIN
ribavirin
TABLET;ORAL202546-004Aug 12, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
RIBAVIRIN
ribavirin
TABLET;ORAL202546-001Aug 12, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
RIBAVIRIN
ribavirin
FOR SOLUTION;INHALATION207366-001Oct 6, 2016ANRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Harvard Business School
Baxter
McKinsey
UBS
Merck
Dow
Chubb
QuintilesIMS
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot